Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Starclose

Related Conditions

Often studied with 12 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed3

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT06665919Not ApplicableCompleted

The Study of CYP2C19 Genotype-Guided Clopidogrel Treatment Models

NCT03596229Completed

Major Adverse Cardiac Events After Carotid Endarterectomy

NCT02455661Not ApplicableCompleted

Femoral Closure Versus Radial Compression Devices Related to Percutaneous Coronary Interventions Study

Showing all 3 trials

Research Network

Common Treatments

  • Starclose1
  • Angioseal1
  • Cyp2c19 Genotypeguided Clopidogrel Treatment1
  • The Conventional Clopidogrel Treatment1
  • Cyp2c19 Genotype Guided Antiplatelet Treatment Alternative To Clopidogrel1

Active Sponsors

  • Tbilisi State Medical University1
  • Universitätsmedizin Mannheim1
  • Mahidol University1
  • Vistamedi Ltd.1

Top Investigators

Related Conditions

  • Access Site Bleeding1
  • Percutaneous Coronary Intervention Pci1
  • Death From Cardiovascular Disease1
  • Coronary Artery Disease1
  • Coronary Thrombosis1

Activity Timeline